Polymyxin B and Trimethoprim Ophthalmic Uses, Dosage, Side Effects and Interactions
Polytrim
Polytrim was the first polymyxin b and trimethoprim ophthalmic product the FDA approved, in October 1988. The FDA now lists it as discontinued; generic polymyxin b and trimethoprim ophthalmic is still listed.
Polymyxin B and Trimethoprim Ophthalmic is a combination antibiotic eye drop used to treat bacterial infections on the surface of the eye, such as bacterial conjunctivitis (pink eye) and blepharoconjunctivitis.
Quick links
Ask Anything About Polymyxin B and Trimethoprim OphthalmicType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Polymyxin B and Trimethoprim Ophthalmic in Short
- Drug classes Dihydrofolate Reductase Inhibitor Antibacterial; Polymyxin-class Antibacterial How the FDA classifies it
What it treatsThis antibiotic eye drop treats surface eye infections caused by bacteria. That includes acute bacterial conjunctivitis (pink eye) and blepharoconjunctivitis (infection of the eyelid edges and the eye surface).
- How you get it Prescription only
- Comes asEye drops (in the eye)Available strengths (polymyxin b/trimethoprim ophthalmic)
- 10000 [USP'U]/mL / 1 mg/mL
- 10000 [IU]/mL / 1 mg/mL
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Polymyxin B and trimethoprim (Polytrim) is an antibiotic eye drop for bacterial infections on the eye's surface, including bacterial pink eye and infections of the eyelid edges and eye surface (blepharoconjunctivitis). It pairs trimethoprim, which blocks an enzyme bacteria need to make DNA, with polymyxin B, which breaks open their outer membrane; on the market since about 1997 with FDA-approved generics listed, it is a common first choice, especially for children. Most people tolerate it well apart from some stinging or burning when it goes in. Watch for an allergic reaction, such as swollen eyelids, worsening redness or a rash around the eye, and stop the drops and call your prescriber if it appears.
Key Takeaways From the HelloPharmacist Team
- Put one drop in each affected eye about every three hours while awake, no more than six times a day.
- Keep going for the full 7 to 10 days your prescriber set, even once the eye looks and feels better.
- Expect no help for pink eye caused by a virus or by allergies, because this drop treats only bacterial infections.
- Children over two months old can use it on the same schedule as adults, but it is not meant for newborn eye infections.
Patient Information Guide for Polymyxin B and Trimethoprim Ophthalmic
What It’s Used For
This combination antibiotic eye drop treats bacterial infections on the surface of the eye.
- Acute bacterial conjunctivitis (pink eye)
- Blepharoconjunctivitis (infection involving the eyelid edges and eye surface)
- Infections caused by susceptible strains of Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans, Haemophilus influenzae and Pseudomonas aeruginosa
How It Works
Two antibiotics work together here. Trimethoprim blocks a bacterial enzyme called dihydrofolate reductase, which bacteria need to make DNA and proteins. It binds far more tightly to the bacterial enzyme than to the human one.
Polymyxin B damages the bacterial cell membrane and kills the bacteria. It is especially active against Pseudomonas aeruginosa.
Drug Class
Drug Class
- Dihydrofolate Reductase Inhibitor Antibacterial from trimethoprim
- Polymyxin-class Antibacterial from polymyxin B
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Polymyxin B and Trimethoprim Ophthalmic has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Dihydrofolate Reductase Inhibitor Antibacterial from trimethoprim
- Polymyxin-class Antibacterial from polymyxin B
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Dihydrofolate Reductase Inhibitors from trimethoprim
- Organic Cation Transporter 2 Inhibitors from trimethoprim
- Cytochrome P450 2C8 Inhibitors from trimethoprim
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Polymyxin B and Trimethoprim Ophthalmic in the FDA’s index.
From our Patient Information GuideTwo antibiotics work together here. Trimethoprim blocks a bacterial enzyme called dihydrofolate reductase, which bacteria need to make DNA and proteins. It binds far more tightly to the bacterial enzyme than to the human one. Polymyxin B damages the bacterial cell membrane and kills the bacteria. Read How Polymyxin B and Trimethoprim Ophthalmic Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Polymyxins from polymyxin B
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Trimethoprim and derivatives from trimethoprim
- Antibiotics from polymyxin B
- Polymyxins from polymyxin B
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
This medicine is used as drops in the affected eye or eyes.
- Adults with mild to moderate infections: one drop about every three hours, up to 6 doses a day, for 7 to 10 days.
- Children over two months old: the same schedule as adults.
Follow your prescriber's directions and your label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Polymyxin B and Trimethoprim Ophthalmic Polymyxin B Trimethoprim Eye Drops
Bacterial infections on the surface of the eye
For people
Highest dose 6 doses per day
- Instill one drop in the affected eye(s) every three hours for a period of 7 to 10 days
Polymyxin B and Trimethoprim Ophthalmic Trimethoprim Polymyxin B Eye Drops
Bacterial infections on the surface of the eye
Adults Highest dose 6 doses per day
- Instill one drop in the affected eye(s) every three hours for a period of 7 to 10 days
Children over two months old Highest dose 6 doses per day
- The dosage regimen is the same as for adults: one drop in the affected eye(s) every three hours for a period of 7 to 10 days
Good to know
For patients over two months of age
Side Effects
The most common problem is irritation of the eye.
Common side effects
- Eye irritation
- Increased redness
- Burning
- Stinging
- Itching
- Swollen eyelids
- Tearing
- Rash around the eye
When to get medical help
- Stop using it and call your doctor if you notice signs of an allergic reaction, such as swollen eyelids, itching, more redness, tearing or a rash around the eye.
- Get emergency help for signs of a severe allergic reaction (anaphylaxis).
- Get emergency help for severe skin reactions such as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis (SJS/TEN), which have been reported.
- Call your doctor if irritation keeps getting worse or appears after you have used the drops for a while.
This can happen when you put the drop in, within 48 hours, or at any time with longer use. Allergic reactions (swollen lids, itching, tearing, rash around the eye) have been reported. Severe reactions such as anaphylaxis and SJS/TEN are rare but serious, so get help right away if they happen.
Warnings and Precautions
- Not for injection into the eye.
- Stop using it if you have a sensitivity or allergic reaction.
- It is not meant for preventing or treating ophthalmia neonatorum (newborn eye infection).
- Irritation can appear later with extended use.
Before You Start
- Do not use it if you are allergic to any of its components.
- Children over two months old can use it at the same schedule as adults.
- It is not for newborn eye infections (ophthalmia neonatorum).
How Your Body Processes It
When used on the skin or mucous membranes, very little of these medicines is absorbed. In a study of 11 volunteers who received two drops in the eye, blood levels of both drugs stayed very low.
Storage
Store at 20° to 25°C (68° to 77°F) . Protect from light.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Polymyxin B and Trimethoprim Ophthalmic Drug Interactions
Polymyxin B and Trimethoprim Ophthalmic: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Polymyxin B and Trimethoprim Ophthalmic — the kind of thing our pharmacy team would talk through with you at the counter.
What is this eye drop for?
How often do I use it, and for how long?
What side effects should I expect?
When should I stop and call someone?
Can I use this if I'm allergic to other antibiotics?
Can it be used for a newborn's eye infection?
Is polymyxin B and trimethoprim ophthalmic available over the counter?
When was polymyxin B and trimethoprim ophthalmic first available?
Who makes polymyxin B and trimethoprim ophthalmic?
What is the brand name of polymyxin B and trimethoprim ophthalmic?
What is the generic name of Polytrim?
What drug class is polymyxin B and trimethoprim ophthalmic?
Is there a generic version of polymyxin B and trimethoprim ophthalmic?
What strengths does polymyxin B and trimethoprim ophthalmic come in?
How much does polymyxin B and trimethoprim ophthalmic cost?
Where can I read the polymyxin B and trimethoprim ophthalmic prescribing information (package insert)?
Is polymyxin B and trimethoprim ophthalmic gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Polymyxin B and Trimethoprim Ophthalmic
Skip the scrolling. Ask in your own words and get an answer from Polymyxin B and Trimethoprim Ophthalmic’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Polymyxin B and Trimethoprim Ophthalmic’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Polymyxin B and Trimethoprim Ophthalmic on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Polymyxin B and Trimethoprim Ophthalmic Forms and Strengths (How It Comes)
Polymyxin B and Trimethoprim Ophthalmic comes in 1 dose form, the eye drops. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Polymyxin B and Trimethoprim Ophthalmic inactive ingredients by manufacturer.
Eye drops
How this form is used
- Polymyxin B Sulfate and Trimethoprim eye drops treat surface bacterial eye infections, including acute bacterial conjunctivitis and blepharoconjunctivitis.
- Polymyxin B Sulfate and Trimethoprim eye drops are placed in the affected eye(s), one drop about every three hours, up to 6 doses a day, for 7 to 10 days in mild to moderate infections.
- Polymyxin B Sulfate and Trimethoprim eye drops are not for injection into the eye.
Polymyxin B and Trimethoprim Ophthalmic on the U.S. Market: Products, Makers and Brands
How Polymyxin B and Trimethoprim Ophthalmic appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
10 companies list 14 Polymyxin B and Trimethoprim Ophthalmic product records with the FDA, mostly as eye drops; the earliest marketing or approval year on record is 1997.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Polymyxin B and Trimethoprim Ophthalmic Is Used (Medicaid Data)
How many Polymyxin B and Trimethoprim Ophthalmic prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Polymyxin B and Trimethoprim Ophthalmic prescribed? Of the 1,682 medications we measure, Polymyxin B and Trimethoprim Ophthalmic ranks #231 by Medicaid prescriptions — more than 86% of them.
Utilization by Polymyxin B and Trimethoprim Ophthalmic product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
Other Polymyxin B and Trimethoprim Ophthalmic products: packs and listings not matched to one strength and form
3 of 26 listed NDCs had Medicaid claims.
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 3 of the 26 listed Polymyxin B and Trimethoprim Ophthalmic NDCs had Medicaid claims.
Compare Polymyxin B and Trimethoprim Ophthalmic Products
A representative set of FDA-listed product records for Polymyxin B and Trimethoprim Ophthalmic — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | A-S Medication Solutions | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Bausch & Lomb Incorporated | ANDA | View NDC → |
| TRIMETHOPRIM SULFATE 1 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Preferred Pharmacetucials Inc. | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| TRIMETHOPRIM SULFATE 1 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Ophthalmic | Proficient Rx LP | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [IU]/mL; TRIMETHOPRIM 1 mg/mL | Ophthalmic | Remedyrepack Inc. | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Remedyrepack Inc. | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Sandoz Inc | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [IU]/mL; TRIMETHOPRIM 1 mg/mL | Ophthalmic | Somerset Therapeutics, LLC | ANDA | View NDC → |
| POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Ophthalmic | Sportpharm LLC | ANDA | View NDC → |
Showing 14 of 14 products — FDA National Drug Code Directory. See every product, package size and price: browse all 14 Polymyxin B and Trimethoprim Ophthalmic NDCs →
Polymyxin B and Trimethoprim Ophthalmic Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Polymyxin B and Trimethoprim Ophthalmic — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Polymyxin B and Trimethoprim Ophthalmic in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Polymyxin B and Trimethoprim Ophthalmic FDA Approval History
How Polymyxin B and Trimethoprim Ophthalmic went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Polymyxin B and Trimethoprim Ophthalmic Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Polymyxin B and Trimethoprim recalls since July 2021.
✅No Polymyxin B and Trimethoprim recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Polymyxin B and Trimethoprim Ophthalmic Supply and Shortage Status
Whether Polymyxin B and Trimethoprim Ophthalmic is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Polymyxin B and Trimethoprim Ophthalmic Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Polymyxin B and Trimethoprim Ophthalmic: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For the generic POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL eye drops, pharmacies paid an average of $0.448 per mL as of Nov 18, 2026, down 4.9% from $0.471 a year earlier.
- What pharmacies pay now
- $0.448
- per mL, as of Nov 18, 2026
- Last 4 weeks
- Down 0.6%
- from $0.451 on Oct 21, 2026
- Last 12 months
- Down 4.9%
- from $0.471 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.380 to $0.556
- per mL
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.448 |
| Oct 2026 | $0.451 |
| Sep 2026 | $0.452 |
| Aug 2026 | $0.452 |
| Jul 2026 | $0.451 |
| Jun 2026 | $0.453 |
| May 2026 | $0.454 |
| Apr 2026 | $0.453 |
| Mar 2026 | $0.459 |
| Feb 2026 | $0.464 |
| Jan 2026 | $0.473 |
| Dec 2025 | $0.476 |
| Nov 2025 | $0.471 |
| Oct 2025 | $0.469 |
| Sep 2025 | $0.471 |
| Aug 2025 | $0.474 |
| Jul 2025 | $0.472 |
| Jun 2025 | $0.469 |
| May 2025 | $0.475 |
| Apr 2025 | $0.481 |
| Mar 2025 | $0.487 |
| Feb 2025 | $0.461 |
| Jan 2025 | $0.435 |
| Dec 2024 | $0.448 |
| Nov 2024 | $0.404 |
| Oct 2024 | $0.535 |
| Sep 2024 | $0.556 |
| Aug 2024 | $0.521 |
| Jul 2024 | $0.437 |
| Jun 2024 | $0.444 |
| May 2024 | $0.380 |
| Apr 2024 | $0.396 |
| Mar 2024 | $0.464 |
| Feb 2024 | $0.441 |
| Jan 2024 | $0.456 |
| Dec 2023 | $0.447 |
| Nov 2023 | $0.472 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Eye drops · Ophthalmic | POLYMYXIN B SULFATE 10000 [IU]/mL; TRIMETHOPRIM 1 mg/mL | Generic | $0.448 per mL | NDC details & price history |
| Eye drops · Ophthalmic | POLYMYXIN B SULFATE 10000 [USP'U]/mL; TRIMETHOPRIM SULFATE 1 mg/mL | Generic | $0.448 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Polymyxin B and Trimethoprim Ophthalmic Brand Names
Polymyxin B and Trimethoprim Ophthalmic has one brand name on record: Polytrim. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Polymyxin B and Trimethoprim Ophthalmic: Manufacturers and Labelers
10 companies list Polymyxin B and Trimethoprim Ophthalmic products with the FDA. By number of product records, the largest are Proficient Rx LP, NuCare Pharmaceuticals,Inc., Remedyrepack Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Polymyxin B and Trimethoprim Ophthalmic Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Remedyrepack Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →